A 25-year prospective study of modified radical mastectomy (Patey) in 193 patients.
Identifieur interne : 001955 ( Pmc/Corpus ); précédent : 001954; suivant : 001956A 25-year prospective study of modified radical mastectomy (Patey) in 193 patients.
Auteurs : M D Staunton ; D M Melville ; A. Monterrosa ; J M ThomasSource :
- Journal of the Royal Society of Medicine [ 0141-0768 ] ; 1993.
Abstract
The results of a prospective study over 20 years of 193 patients with breast carcinoma treated by Patey mastectomy are presented together with details of the operative technique employed. One hundred and twenty-eight cases (66%) were stage 1 (T1/T2 N0), 46 (24%) were stage 2 (T1/T2 N1), 18 (9%) were stage 3 (T3 N0/N1), and one was stage 4 (M1). The probability of survival together with 95% confidence intervals for stage 1 (T1/T2 N0) at 10 years was 79% (71-88); and at 15 years 74% (61-87). For stage 2 (T1/T2 N1), the probability of survival at 10 years was 64% (48-79), and at 15 years 60% (44-76). For stage 3 (T3 N0/N1), the probability of survival at 10 years was 70% (45-95) and nobody survived at 15 years. These differences between the clinical stages lacked significance [Log-rank test: chi 2 = 3.44 df = 2 P = 0.18]. There were nine patients (5%) who developed local recurrence without systemic metastases. There was no postoperative mortality, and morbidity was low. Axillary node metastases depressed survival with probability of survival at 10 years 43% (29-57) in contrast to those without it 90% (84-96) [log-rank test: chi 2 = 39.42 df = 1 P < 0.0001]. Patey mastectomy should be considered for patients with T1 or T2 tumours who choose mastectomy rather than breast conservation. It is an effective local treatment which is of particular relevance in countries where radiotherapy is not available.
Url:
PubMed: 8371243
PubMed Central: 1293004
Links to Exploration step
PMC:1293004Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A 25-year prospective study of modified radical mastectomy (Patey) in 193 patients.</title>
<author><name sortKey="Staunton, M D" sort="Staunton, M D" uniqKey="Staunton M" first="M D" last="Staunton">M D Staunton</name>
</author>
<author><name sortKey="Melville, D M" sort="Melville, D M" uniqKey="Melville D" first="D M" last="Melville">D M Melville</name>
</author>
<author><name sortKey="Monterrosa, A" sort="Monterrosa, A" uniqKey="Monterrosa A" first="A" last="Monterrosa">A. Monterrosa</name>
</author>
<author><name sortKey="Thomas, J M" sort="Thomas, J M" uniqKey="Thomas J" first="J M" last="Thomas">J M Thomas</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">8371243</idno>
<idno type="pmc">1293004</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1293004</idno>
<idno type="RBID">PMC:1293004</idno>
<date when="1993">1993</date>
<idno type="wicri:Area/Pmc/Corpus">001955</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001955</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">A 25-year prospective study of modified radical mastectomy (Patey) in 193 patients.</title>
<author><name sortKey="Staunton, M D" sort="Staunton, M D" uniqKey="Staunton M" first="M D" last="Staunton">M D Staunton</name>
</author>
<author><name sortKey="Melville, D M" sort="Melville, D M" uniqKey="Melville D" first="D M" last="Melville">D M Melville</name>
</author>
<author><name sortKey="Monterrosa, A" sort="Monterrosa, A" uniqKey="Monterrosa A" first="A" last="Monterrosa">A. Monterrosa</name>
</author>
<author><name sortKey="Thomas, J M" sort="Thomas, J M" uniqKey="Thomas J" first="J M" last="Thomas">J M Thomas</name>
</author>
</analytic>
<series><title level="j">Journal of the Royal Society of Medicine</title>
<idno type="ISSN">0141-0768</idno>
<imprint><date when="1993">1993</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>The results of a prospective study over 20 years of 193 patients with breast carcinoma treated by Patey mastectomy are presented together with details of the operative technique employed. One hundred and twenty-eight cases (66%) were stage 1 (T1/T2 N0), 46 (24%) were stage 2 (T1/T2 N1), 18 (9%) were stage 3 (T3 N0/N1), and one was stage 4 (M1). The probability of survival together with 95% confidence intervals for stage 1 (T1/T2 N0) at 10 years was 79% (71-88); and at 15 years 74% (61-87). For stage 2 (T1/T2 N1), the probability of survival at 10 years was 64% (48-79), and at 15 years 60% (44-76). For stage 3 (T3 N0/N1), the probability of survival at 10 years was 70% (45-95) and nobody survived at 15 years. These differences between the clinical stages lacked significance [Log-rank test: chi 2 = 3.44 df = 2 P = 0.18]. There were nine patients (5%) who developed local recurrence without systemic metastases. There was no postoperative mortality, and morbidity was low. Axillary node metastases depressed survival with probability of survival at 10 years 43% (29-57) in contrast to those without it 90% (84-96) [log-rank test: chi 2 = 39.42 df = 1 P < 0.0001]. Patey mastectomy should be considered for patients with T1 or T2 tumours who choose mastectomy rather than breast conservation. It is an effective local treatment which is of particular relevance in countries where radiotherapy is not available.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J R Soc Med</journal-id>
<journal-title>Journal of the Royal Society of Medicine</journal-title>
<issn pub-type="ppub">0141-0768</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">8371243</article-id>
<article-id pub-id-type="pmc">1293004</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>A 25-year prospective study of modified radical mastectomy (Patey) in 193 patients.</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Staunton</surname>
<given-names>M D</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Melville</surname>
<given-names>D M</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Monterrosa</surname>
<given-names>A</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Thomas</surname>
<given-names>J M</given-names>
</name>
</contrib>
</contrib-group>
<aff>General Surgery Department, St Bartholomew's Hospital, London.</aff>
<pub-date pub-type="ppub"><month>7</month>
<year>1993</year>
</pub-date>
<volume>86</volume>
<issue>7</issue>
<fpage>381</fpage>
<lpage>384</lpage>
<abstract><p>The results of a prospective study over 20 years of 193 patients with breast carcinoma treated by Patey mastectomy are presented together with details of the operative technique employed. One hundred and twenty-eight cases (66%) were stage 1 (T1/T2 N0), 46 (24%) were stage 2 (T1/T2 N1), 18 (9%) were stage 3 (T3 N0/N1), and one was stage 4 (M1). The probability of survival together with 95% confidence intervals for stage 1 (T1/T2 N0) at 10 years was 79% (71-88); and at 15 years 74% (61-87). For stage 2 (T1/T2 N1), the probability of survival at 10 years was 64% (48-79), and at 15 years 60% (44-76). For stage 3 (T3 N0/N1), the probability of survival at 10 years was 70% (45-95) and nobody survived at 15 years. These differences between the clinical stages lacked significance [Log-rank test: chi 2 = 3.44 df = 2 P = 0.18]. There were nine patients (5%) who developed local recurrence without systemic metastases. There was no postoperative mortality, and morbidity was low. Axillary node metastases depressed survival with probability of survival at 10 years 43% (29-57) in contrast to those without it 90% (84-96) [log-rank test: chi 2 = 39.42 df = 1 P < 0.0001]. Patey mastectomy should be considered for patients with T1 or T2 tumours who choose mastectomy rather than breast conservation. It is an effective local treatment which is of particular relevance in countries where radiotherapy is not available.</p>
</abstract>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001955 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 001955 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Pmc |étape= Corpus |type= RBID |clé= PMC:1293004 |texte= A 25-year prospective study of modified radical mastectomy (Patey) in 193 patients. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:8371243" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |